Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03YIT
|
|||
| Former ID |
DIB005118
|
|||
| Drug Name |
CL-186659
|
|||
| Synonyms |
IDDB8406
Click to Show/Hide
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Terminated | [1] | |
| Company |
Lederle Laboratories
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Staphylococcus Beta-lactamase (Stap-coc blaZ) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004648) | |||
| REF 2 | US patent application no. 2004,0023,290, Novel therapeutic agents that modulate enzymatic processes. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.